My buddy Marcus caught me at the gym a few months back, mid-set, and asked me point blank: “How long before I start seeing something from this sermorelin stuff?” He’d read somewhere online that four to six weeks was the magic number. He’d already circled it on his calendar like a countdown to a fight.
Here’s the thing. I went looking for where that number came from. I couldn’t find it. Not in a real trial, not in a study, nowhere. It’s the kind of figure that gets repeated so often it starts to feel true, even though nobody can point to where it was actually measured.
So let me be straight with you about what this piece is and isn’t. It isn’t going to hand you a tidy “week 3, week 6, week 12” countdown for every peptide men over 40 are curious about. What it will do is walk you through what the actual human trials measured, when they measured it, and just as important, what they never measured at all. Because a lot of what’s sold as a “results timeline” in this space is fiction dressed up as science, and a man deserves better than fiction when he’s deciding what to put in his body.
Two clocks, and most marketing only shows you one
Here’s the distinction that took me a while to really get, and once you see it you can’t unsee it. There are two completely different clocks running in this world of compounds. One clock tracks a number in your bloodwork. The other tracks something you’d actually notice, more energy, less soreness, a leaner waistline, a tendon that finally stops barking at you. These two clocks do not run at the same speed, and they are frequently not even connected in the data at all.
Some of these compounds move the bloodwork clock fast, days to a couple of weeks. Whether that turns into the felt clock, the one you actually care about, is a much shakier question, and for a few of these compounds it’s a question nobody has answered in humans yet.
Running the trials side by side
I want to walk you through what I found compound by compound, because the pattern only becomes obvious once you line them up.
Testosterone isn’t really racing a clock at all. It’s dosed to hit a target range and then monitored, sometimes for years. The evidence here is the strongest in the category, but it only applies to men with an actual diagnosed deficiency, and the benefits and the risks were both tracked over months, not weeks [1].
Sermorelin, the peptide Marcus was asking about, does move a lab number fast. A study from 1992 gave older men the active GHRH fragment twice a day for two weeks and documented growth hormone and IGF-1 climbing back toward youthful levels in that window [2]. That’s real. But how much benefit you actually feel depends a lot on the dosing schedule, and multiple daily doses beat a single nightly shot in the trial data we have [3].
CJC-1295 is the most dramatic mover on paper. A 2006 study found a single injection drove growth hormone up 2- to 10-fold, with IGF-1 staying elevated for 9 to 11 days [4]. Read that twice, because it’s an impressive number. But no trial I could find showed that number translating into a body-composition change on any stated timeline. The pharmacology is documented. The payoff isn’t.
Ipamorelin actually disappointed in its best controlled human trial. The measured endpoint missed statistical significance (p = 0.15) [5]. That’s not a peptide with a fast timeline or a slow timeline. It’s one where the rigorous test came back null.
BPC-157, the one I hear about most from guys chasing an old shoulder or knee injury, has no human timeline whatsoever. A 2025 systematic review looked at the evidence and found it’s almost entirely animal and cell studies, with no clinical safety data in humans and no FDA-approved use [6]. I’ll say that plainly below, because it deserves its own space.
NAD+ precursors raised blood NAD+ levels in a 2018 placebo-controlled trial of healthy middle-aged and older adults [7]. That number moved, cleanly and measurably. What didn’t move, or wasn’t shown to move, was the felt energy or anti-aging benefit the supplement aisle promises.
Why the fastest numbers deserve the most suspicion
Here’s what got under my skin once I really sat with these studies. The compounds with the flashiest, fastest biomarker movement are exactly the ones with the thinnest evidence for anything you’d actually notice.
Think about CJC-1295 again. “Growth hormone up 2 to 10 fold” sounds like a headline built for a sales page, and it gets used like one [4]. But that number describes a hormone floating around in your blood. It says nothing about muscle on your frame or how your knees feel climbing stairs at week six. When a website borrows that real, documented number and quietly welds it onto a promise about how you’ll look in a month, it’s splicing two separate things together, one measured and one invented. Trust the first half of that sentence. Be skeptical of the second half.
NAD+ precursors tell almost the identical story with a different molecule. The 2018 trial proved the blood number rises [7]. It did not prove that people felt younger, sharper, or more energetic. Two clocks, one confirmed, one not, and IV drip clinics selling the second one on the confidence of the first.
The one with no clock at all
If you take one thing from this whole piece, let it be this. BPC-157 doesn’t have a slow timeline or an uncertain timeline. It has no timeline, because it has essentially no human data [6]. Every “heals your tendon in three weeks” claim you’ve seen for it was extrapolated from a rat or a petri dish, not measured in a person. I’m not saying that to scare you off entirely, plenty of interesting biology starts in animal studies. I’m saying it because a blank is not the same as a bad number, and pretending otherwise is where a lot of the dishonesty in this category lives.
Testosterone runs on its own calendar
Testosterone deserves a different kind of respect, because it isn’t chasing a countdown at all. The TRAVERSE trial, published in the New England Journal of Medicine in 2023, followed 5,246 middle-aged and older men with diagnosed low testosterone and cardiovascular risk, comparing testosterone gel to placebo over an extended stretch of time [1]. Testosterone came out noninferior to placebo for major cardiac events, but the researchers were honest that atrial fibrillation showed up more often in the testosterone group [1]. That’s not a “six weeks and you’ll feel it” study. It’s a monitoring relationship.
And here’s the part I think gets skipped the most. The safest, most honest version of a testosterone timeline doesn’t start with the first dose. It starts with getting your labs drawn and confirming you actually have a deficiency, because the benefits and the documented risks in the trial data only apply to that group [1]. Skipping straight to a needle doesn’t speed anything up. It just cuts out the step that protects you.
The clock that has nothing to do with your body
There’s one more timeline worth mentioning, and it isn’t biological at all. Under the 2026 WADA Prohibited List, peptide hormones, growth factors, and growth-hormone secretagogues sit under class S2 and are banned in competitive sport, and testosterone is banned too [8]. If you’re a masters athlete or you compete in anything drug-tested, the timeline that matters most might not be weeks to a result. It might be one test to a positive, and a “research use only” label on a vial does nothing to protect you from that.
What I actually tell Marcus now
When I brought all this back to Marcus, here’s roughly what I said. The bloodwork numbers for growth-hormone peptides are real and they move fast, sometimes within days [2][4]. But the things you’d actually feel, less soreness, visible changes, better recovery, are far less proven, much slower where they’ve been shown at all, and in a few cases were never demonstrated to happen on any timeline [5][6][7]. Testosterone is the outlier with strong evidence, but it’s a monitored, months-long relationship for men with confirmed deficiency, not a quick fix [1]. And BPC-157’s honest answer is that there’s no number to give at all [6].
That spread is exactly why I don’t trust anyone handing out a fixed countdown. These studies give you population averages and lab windows, not your personal answer. Your actual timeline depends on your labs, your dose, your starting point, and what you’re even measuring, and that’s the kind of individualized read a clinician gives you, not something a checkout page can spit out. A setup where a licensed clinician evaluates you, writes a protocol if it’s appropriate, a licensed pharmacy fills it, and someone actually tracks how you respond over time, that’s the structure that turns these population numbers into something meaningful for you. FormBlends operates as one physician-supervised path built that way. I’m not telling you to buy anything, there’s nothing to buy here, just naming the kind of setup that makes a timeline mean something instead of being a guess on a label.
Set your expectations by what the data actually shows, not by what a sales page wishes were true. Where the numbers are real, respect them. Where there’s a blank, treat the blank as your answer. And remember the only timeline that really matters is yours, tracked by someone qualified to read it, not a countdown circled on a calendar.
Questions I get asked a lot
How long do peptides actually take to work for a guy over 40? Depends which clock you’re asking about. The blood-marker clock for growth-hormone peptides is fast, days to about two weeks in the trial data [2][4]. The clock for something you’d actually feel, body composition, recovery, is slower and shakier, and for a few compounds it was never shown to move at all [5][6][7]. Any single number that ignores that split is marketing, not evidence.
Why do sales pages promise “results in 4 to 6 weeks” when the real data doesn’t say that? Because most of those numbers were never measured, they were invented. The real, impressive figures that do exist, like growth hormone jumping 2- to 10-fold, describe a hormone in your bloodstream, not muscle you can see in the mirror [4]. Sales copy borrows that real number and quietly reattaches it to a promise about your appearance in a month. Trust the biomarker figure. Distrust the splice.
How long does BPC-157 take to heal an injury? There’s no honest timeline to give you. A 2025 systematic review found the evidence is almost entirely preclinical, animal and cell studies, with no clinical safety data in humans and no FDA-approved use [6]. Every confident “heals in X weeks” claim for BPC-157 comes from a rodent study, not a person. The blank is the finding.
If my lab number changes, will I feel different on the same schedule? No, and mixing those two up is the most common mistake I see. The NAD+ trial from 2018 showed blood NAD+ rising during supplementation, but it did not show people felt more energetic or aged more slowly [7]. A number moving and a feeling changing are separate clocks with very different levels of proof behind them.
Why does testosterone get treated differently on this page? Because it isn’t a countdown, it’s a monitored relationship. The TRAVERSE trial followed 5,246 men over months and years, not weeks, tracking both benefits and risks like atrial fibrillation [1]. It also only applies to men with a confirmed deficiency, so the honest first step of any timeline is labs and diagnosis, not the first injection.
Why can’t someone just give me a fixed number and be done with it? Because the published numbers are averages across groups of people, not a prediction about you specifically. Your real answer depends on your labs, your dose, your starting point, and what’s actually being tracked, which is exactly the kind of individualized read a clinician provides. A model where a licensed clinician evaluates you, a licensed pharmacy fills what’s appropriate, and someone follows your progress, the kind of setup FormBlends operates as one physician-supervised example of, is what turns population data into something that means anything for your own body.
How long do trials show it actually takes for peptides like sermorelin or CJC-1295 to produce noticeable changes in men over 40?
Most controlled trials clock meaningful changes at 8 to 12 weeks of consistent dosing. Body composition shifts, specifically modest reductions in visceral fat and some lean mass gain, tend to show up on DEXA scans around that window. Sleep quality improvements are often reported earlier, sometimes within two to four weeks, though individual response varies quite a bit depending on baseline hormone levels and lifestyle factors.
Are peptides actually safe for men over 40, or is that just marketing?
The safety picture is genuinely mixed and depends heavily on the specific peptide and how it is sourced. Growth hormone secretagogues like sermorelin have a reasonable short-term safety record in clinical settings. The bigger risk for most men is not the molecule itself but buying unregulated research-chemical versions with no verified purity or dosing accuracy. Sourcing through a physician-supervised compounding pharmacy like FormBlends is a materially different risk profile than ordering from a grey-market supplier.
Do peptides actually work for fat loss and muscle in middle-aged men, or is the evidence still too thin to say?
The honest answer is that the evidence is promising but limited in scope. Several small trials show measurable improvements in growth hormone pulse amplitude, lean mass, and fat oxidation in men over 40. What the trials do not show clearly yet is whether those changes translate into long-term, clinically significant outcomes. Peptides are not a substitute for resistance training and adequate protein, and any trial data that ignores those variables should be read cautiously.
What should men over 40 actually look for when comparing peptides, given how many options are being marketed right now?
Start with mechanism and half-life. Sermorelin has a very short half-life and mimics natural pulsatile GH release closely. CJC-1295 with DAC stays active much longer, which some researchers think blunts the natural pulse pattern over time. BPC-157 is a different category entirely, aimed at tissue repair rather than hormone signaling. Match the peptide to a specific, measurable goal, and be skeptical of any source that sells multiple peptides as a single stack without clinical rationale.
References
- Lincoff AM, et al. “Cardiovascular Safety of Testosterone-Replacement Therapy” (TRAVERSE). N Engl J Med. 2023 (n=5,246; noninferior for MACE; more atrial fibrillation; multi-month monitored trial). https://pubmed.ncbi.nlm.nih.gov/37326322/
- Corpas E, et al. “Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.” J Clin Endocrinol Metab. 1992 (two-week dosing course). https://pubmed.ncbi.nlm.nih.gov/1379256/
- Vittone J, et al. “Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.” Metabolism. 1997 (single nightly dosing less effective than multiple daily doses).
- Teichman SL, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006 (GH up 2- to 10-fold; IGF-1 elevated 9 to 11 days).
- Beck DE, et al. “Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.” Int J Colorectal Dis. 2014 (missed primary endpoint, p = 0.15).
- Vasireddi N, et al. “Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.” HSS Journal. 2025 (mostly preclinical; no clinical safety data in humans; no FDA-approved indication).
- Martens CR, et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nat Commun. 2018.
- USADA. “2026 WADA Prohibited List” (S2: peptide hormones, growth factors, and GH secretagogues prohibited in sport).
